TY - JOUR
T1 - Nontypeable Haemophilus influenzae-binding gangliosides of human respiratory (HEp-2) cells have a requisite lacto/neolacto core structure
AU - Berenson, Charles S.
AU - Sayles, Kelly B.
AU - Huang, Jing
AU - Reinhold, Vernon N.
AU - Garlipp, Mary Alice
AU - Yohe, Herbert C.
N1 - Funding Information:
The authors are grateful for the assistance of Timothy F. Murphy, M.D., for offering scientific advice and for critically reading this manuscript, and for the technical assistance of Ms. Jane M. Smigiera. This work was supported by research grant 1RO1HL6654901 from the National Institutes of Health (CSB) and by Merit Review funding of the Department of Veteran’s Affairs (HCY).
PY - 2005/8/1
Y1 - 2005/8/1
N2 - Nontypeable Haemophilus influenzae (NTHI) are a major cause of human infections. We previously demonstrated high affinity and high specificity binding of NTHI to minor gangliosides of human respiratory (HEp-2) cells and macrophages, but not to brain gangliosides. We further identified the NTHI-binding ganglioside of human macrophages as α2,3- sialylosylparagloboside (IV3NeuAc-nLcOse4Cer, nLM1), which possesses a neolacto core structure that is absent in brain gangliosides. This supported a hypothesis that lacto/neolacto core carbohydrates are critical for NTHI-ganglioside binding. To investigate, we determined the core carbohydrate structure of NTHI-binding gangliosides of HEp-2 cells, through multiple approaches, including specific enzymatic degradation, mass spectral analysis and gas-liquid chromatography. Our analyses denote the following critical structural attributes of NTHI-binding gangliosides: (1) a conserved lacto/neolacto core structure; (2) requisite sialylation, which may be either internal or external, with α2,3 (human macrophages) or α2,6 (HEp-2 cells) anomeric linkages; (3) internalized galactose residues. Mass spectral and gas chromatographic analyses confirm that NTHI-binding gangliosides of HEp-2 cells possess lacto/neolacto carbohydrate cores and identify the structure of the major peak as NeuAcα2-6Galβ1-4GlcNAcβ1-3Galβ1- 4Glcβ1-1Cer (α2,6-sialosylparagloboside, nLM1). Collectively, our studies denote NTHI-binding gangliosides as lacto/neolacto series structures.
AB - Nontypeable Haemophilus influenzae (NTHI) are a major cause of human infections. We previously demonstrated high affinity and high specificity binding of NTHI to minor gangliosides of human respiratory (HEp-2) cells and macrophages, but not to brain gangliosides. We further identified the NTHI-binding ganglioside of human macrophages as α2,3- sialylosylparagloboside (IV3NeuAc-nLcOse4Cer, nLM1), which possesses a neolacto core structure that is absent in brain gangliosides. This supported a hypothesis that lacto/neolacto core carbohydrates are critical for NTHI-ganglioside binding. To investigate, we determined the core carbohydrate structure of NTHI-binding gangliosides of HEp-2 cells, through multiple approaches, including specific enzymatic degradation, mass spectral analysis and gas-liquid chromatography. Our analyses denote the following critical structural attributes of NTHI-binding gangliosides: (1) a conserved lacto/neolacto core structure; (2) requisite sialylation, which may be either internal or external, with α2,3 (human macrophages) or α2,6 (HEp-2 cells) anomeric linkages; (3) internalized galactose residues. Mass spectral and gas chromatographic analyses confirm that NTHI-binding gangliosides of HEp-2 cells possess lacto/neolacto carbohydrate cores and identify the structure of the major peak as NeuAcα2-6Galβ1-4GlcNAcβ1-3Galβ1- 4Glcβ1-1Cer (α2,6-sialosylparagloboside, nLM1). Collectively, our studies denote NTHI-binding gangliosides as lacto/neolacto series structures.
KW - Bacterial adherence
KW - Gangliosides
KW - Glycosphingolipids
KW - Haemophilus influenzae
UR - http://www.scopus.com/inward/record.url?scp=22844439983&partnerID=8YFLogxK
U2 - 10.1016/j.femsim.2005.03.007
DO - 10.1016/j.femsim.2005.03.007
M3 - Article
C2 - 16051069
AN - SCOPUS:22844439983
SN - 0928-8244
VL - 45
SP - 171
EP - 182
JO - FEMS Immunology and Medical Microbiology
JF - FEMS Immunology and Medical Microbiology
IS - 2
ER -